Core Viewpoint - The recent backlash against actor Xiao Zhan from his fans regarding the upcoming medical drama "Liu Yisheng Returns Home" highlights the challenges and sensitivities surrounding medical-themed productions in the current market [1][2]. Group 1: Industry Challenges - Medical dramas are notoriously difficult to produce, often resulting in poor quality due to a lack of understanding of medical practices and terminology by the creative teams [3][6]. - A survey conducted by a professional medical forum revealed that 85.8% of doctors identified errors in medical dramas, indicating a significant gap between medical accuracy and entertainment [4]. - The production of medical dramas faces logistical challenges, such as securing filming locations and medical equipment, which complicates the creation of realistic settings [6][8]. Group 2: Market Reception - The market response to medical dramas has been largely negative, with many past productions failing to resonate with audiences, leading to a decline in interest in the genre [9][11]. - Despite a resurgence of medical dramas post-pandemic, the quality of storytelling remains a concern, as even well-received shows struggle to achieve high viewership numbers [11][12]. - Recent medical dramas have not been able to attract significant audience engagement, with some shows recording average ratings as low as 0.2% [11]. Group 3: Future Prospects - There is a recognized need for compelling medical dramas that resonate with ordinary viewers, focusing on relatable human stories rather than glorifying the medical profession [15]. - The potential for future medical dramas exists as the industry moves towards greater industrialization and exploration of deeper narratives within the medical context [12][15].